These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8772588

  • 1. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes.
    Dong Q, Brucker-Davis F, Weintraub BD, Smallridge RC, Carr FE, Battey J, Spiegel AM, Shenker A.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1134-40. PubMed ID: 8772588
    [Abstract] [Full Text] [Related]

  • 2. Pituitary adenomas: screening for G alpha q mutations.
    Oyesiku NM, Evans CO, Brown MR, Blevins LS, Tindall GT, Parks JS.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4184-8. PubMed ID: 9398737
    [Abstract] [Full Text] [Related]

  • 3. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms.
    Reincke M, Karl M, Travis W, Chrousos GP.
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1419-22. PubMed ID: 8077343
    [Abstract] [Full Text] [Related]

  • 4. Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia.
    Ringel MD, Saji M, Schwindinger WF, Segev D, Zeiger MA, Levine MA.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):554-9. PubMed ID: 9467574
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.
    Harris PE, Alexander JM, Bikkal HA, Hsu DW, Hedley-Whyte ET, Klibanski A, Jameson JL.
    J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386
    [Abstract] [Full Text] [Related]

  • 6. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
    Faccenda E, Melmed S, Bevan JS, Eidne KA.
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
    [Abstract] [Full Text] [Related]

  • 7. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
    Matsuo K, Friedman E, Gejman PV, Fagin JA.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
    [Abstract] [Full Text] [Related]

  • 8. A novel transcript for the thyrotropin-releasing hormone receptor in human pituitary and pituitary tumors.
    Yamada M, Hashimoto K, Satoh T, Shibusawa N, Kohga H, Ozawa Y, Yamada S, Mori M.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4224-8. PubMed ID: 9398744
    [Abstract] [Full Text] [Related]

  • 9. Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas.
    Farrell WE, Talbot JA, Bicknell EJ, Simpson D, Clayton RN.
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):241-4. PubMed ID: 9302401
    [Abstract] [Full Text] [Related]

  • 10. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
    Tordjman K, Stern N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjöld M, Friedman E.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Expression of a novel transcript for the TRH receptor in human pituitary adenomas].
    Yamada M, Mori M.
    Nihon Rinsho; 1999 Mar; 57(3):737-45. PubMed ID: 10199161
    [Abstract] [Full Text] [Related]

  • 13. Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumors.
    Lee EJ, Kotlar TJ, Ciric I, Lee MK, Lim SK, Lee HC, Huh KB, Mayo KE, Jameson JL.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3989-95. PubMed ID: 11502843
    [Abstract] [Full Text] [Related]

  • 14. Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11.
    Hsieh KP, Martin TF.
    Mol Endocrinol; 1992 Oct; 6(10):1673-81. PubMed ID: 1333052
    [Abstract] [Full Text] [Related]

  • 15. [TRH receptor].
    Yamada M, Mori M.
    Nihon Rinsho; 1998 Jul; 56(7):1931-7. PubMed ID: 9702078
    [Abstract] [Full Text] [Related]

  • 16. Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.
    Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y.
    Eur J Endocrinol; 1995 Aug; 133(2):166-72. PubMed ID: 7655640
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
    Yang I, Park S, Ryu M, Woo J, Kim S, Kim J, Kim Y, Choi Y.
    Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
    [Abstract] [Full Text] [Related]

  • 18. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
    Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, Frazzatto ET, Mendonca BB, Villares SM.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
    [Abstract] [Full Text] [Related]

  • 19. G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas.
    Boothroyd CV, Grimmond SM, Cameron DP, Hayward NK.
    Biochem Biophys Res Commun; 1995 Jun 26; 211(3):1063-70. PubMed ID: 7598693
    [Abstract] [Full Text] [Related]

  • 20. Thyrotropin expression in hypophyseal pars tuberalis-specific cells is 3,5,3'-triiodothyronine, thyrotropin-releasing hormone, and pit-1 independent.
    Bockmann J, Böckers TM, Winter C, Wittkowski W, Winterhoff H, Deufel T, Kreutz MR.
    Endocrinology; 1997 Mar 26; 138(3):1019-28. PubMed ID: 9048604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.